Instylla Stock

www.instylla.com/Healthcare / Medical DevicesFounded: 2017

Instylla, founded in 2017, is a medical equipment supplier that strives to specialize in liquid embolics for interventional radiology. Their objective is to develop next-generation liquid embolics for radiology, with early medical applications in peripheral hemostasis and interventional oncology. The first Instylla product, Embrace™ Hydrogel Embolic System (HES), is designed to use a water-based PEG hydrogel during the embolization procedure. Instylla is headquartered in Bedford, Massachusetts.

Register for Details

For more details on financing and valuation for Instylla, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Instylla.

Register Today

Instylla investors also invested in these private companies

Catalyst Health Ventures
Sparta Group
Ascension Ventures
AMED Ventures
Excelestar Ventures
Angel Physicians Fund
Delos Capital Partners
Incept

Team

Management Team

Raymond Lareau
President
Amarpreet Sawhney Ph.D
Founder & Chief Executive Officer

Board Members

Darshana Zaveri
Catalyst Health Ventures
Henry Chen JD
Delos Capital Partners
Tara Butler MD
Ascension Ventures
Tasneem Dohadwala
Excelestar Ventures

Other companies like Instylla in the Medical Devices sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$263MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$943.68MM
Sector
Last Round Est. Valuation
$403.11MM
Sector
Last Round Est. Valuation
$1.35B
Sector
Last Round Est. Valuation
$893.88MM

News Highlights

Instylla Closes $30M Equity Financing
Instylla, Inc., a Bedford, MA-based company developing next-generation liquid embolics for peripheral vascular embolotherapy, closed a $30m financing round. This round was led by new investor Delos Capital, with continued participation from the investor syndicate of Excelestar Ventures, Ascension Ventures, Catalyst Health Ventures, Amed Ventures, Sparta Group, and Incept, LLC.
Updated on: Oct 3, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.